Please Wait.....
Report
Gene Therapy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
Market Report I 2023-05-29 I 142 Pages I IMARC Group
The global gene therapy market size reached US$ 4.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 10.9 Billion by 2028, exhibiting a growth rate (CAGR) of 15.39% during 2023-2028. The growing prevalence of inherited diseases and acquired disorders; increasing construction of hospitals, clinics, and nursing homes; and rising popularity of new gene therapy that offers a safer, non-addictive alternative to opioids represent some of the key factors driving the market.
Rising Occurrence of Chronic Diseases Augmenting Market Growth
The increasing prevalence of various chronic diseases among the masses represents one of the key factors propelling the growth of the gene therapy market. Besides this, the occurrence of various chronic diseases, such as cardiovascular complications, diabetes, thyroiditis, and obesity, due to the adoption of unhealthy lifestyle patterns is contributing to the growth of the market. Moreover, rising cases of cancer among the masses, along with the growing demand for effective oncology treatment, is offering a favorable market outlook. Furthermore, the increasing occurrence of chronic lung diseases due to excessive smoking habits is bolstering the growth of the gene therapy market.
Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. The structure of the gene therapy market is moderately fragmented due to the presence of a large number of global and regional players. The volume of new entrants in the market is moderate due to the requirement for high capital investments, stringent government policies, and the rate of product differentiation is low.
What is Gene Therapy?
Gene therapy is a technique for preventing disease progression by modifying the expression of mutated genes or altering the biological properties of living cells for therapeutic use. It comprises different products, such as viral vectors, bacterial vectors, plasmid deoxyribonucleic acid (DNA), human gene-editing technology, and patient-derived cellular gene therapy. It involves the introduction of a healthy gene into the genome of an individual to repair a mutation that is causing a genetic disorder. It consists of various therapies, such as ex vivo, in vivo, and in situ gene therapy. Gene therapy functions via gene inhibition, gene augmentation, and ultimately killing the disease-causing cells. It can cure certain diseases which no medications can prevent and has the potential to get rid of disease symptoms permanently. It also improves the ability of the body to fight against a wide variety of diseases, such as cancer, diabetes, hemophilia, cystic fibrosis, heart disease, and acquired immunodeficiency syndrome (AIDS). Furthermore, as gene therapy does not require multiple doses like other medications, its demand is increasing around the world.
COVID-19 Impact:
The outbreak of coronavirus severely disrupted the gene therapy market and affected the performance of various biopharmaceutical companies. Some gene therapy companies faced an immense number of complications due to their complicated manufacturing and delivery systems and funding models. The manufacture and delivery of treatment, research and clinical development, and commercial operations were negatively impacted by the pandemic, which resulted in a disruption in the growth of the gene therapy market. In addition, the supply chains that support the manufacturing and development of gene therapy products require controlled and complex settings. The supply chain was severely impacted by lockdowns and restrictions imposed on movement via roads. Furthermore, several companies reported delays or complete halts in operations due to the outbreak of COVID-19.
Gene Therapy Market Trends:
At present, the growing demand for gene therapy, as it is effective in curing various critical and life-threatening diseases, represents one of the primary factors influencing the market positively. Besides this, the rising prevalence of inherited diseases and acquired disorders among the masses is propelling the growth of the market. In addition, the increasing construction of hospitals, clinics, and nursing homes around the world to provide quality healthcare services to patients is contributing to the growth of the market. Apart from this, the rising popularity of new gene therapy that offers a safer and non-addictive alternative to opioids in treating a broad range of chronic pain conditions, such as lower back pain and rare neuropathic pain disorders, is offering a favorable market outlook.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global gene therapy market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on gene type, vector type, delivery method and application.
Gene Type Insights:
Antigen
Cytokine
Tumor Suppressor
Suicide Gene
Deficiency
Growth Factors
Receptors
Others
The report has provided a detailed breakup and analysis of the gene therapy market based on the gene type. This includes antigen, cytokine, tumor suppressor, suicide gene, deficiency, growth factors, receptors, and others.
Vector Type Insights:
Viral Vector
Adenoviruses
Lentiviruses
Retroviruses
Adeno-Associated Virus
Herpes Simplex Virus
Poxvirus
Vaccinia Virus
Others
Non-Viral Techniques
Naked and Plasmid Vectors
Gene Gun
Electroporation
Lipofection
Others
A detailed breakup and analysis of the gene therapy market based on the vector type has also been provided in the report. This includes viral vector (adenoviruses, lentiviruses, retroviruses, adeno-associated virus, herpes simplex virus, poxvirus, vaccinia virus, and others) and non-viral techniques (naked and plasmid vectors, gene gun, electroporation, lipofection, and others). According to the report, viral vector (adenoviruses, lentiviruses, retroviruses, adeno-associated virus, herpes simplex virus, poxvirus, vaccinia virus, and others) accounted for the largest market share as it is highly efficient in mitigating the impacts of infectious diseases and viruses. In addition, the rising utilization of viral vectors as they are easy to handle and modify is propelling the growth of the respective segment.
Delivery Method Insights:
In-Vivo Gene Therapy
Ex-Vivo Gene Therapy
A detailed breakup and analysis of the gene therapy market based on the delivery method has also been provided in the report. This includes in-vivo gene therapy and ex-vivo gene therapy.
Application Insights:
Oncological Disorders
Rare Diseases
Cardiovascular Diseases
Neurological Disorders
Infectious Disease
Others
A detailed breakup and analysis of the gene therapy market based on the application has also been provided in the report. This includes oncological disorders, rare diseases, cardiovascular diseases, neurological disorders, infectious disease, and others. According to the report, oncological disorders accounted for the largest market share due to increasing occurrence of cancer among the masses. Apart from this, the rising employment of gene therapy in cancer treatment as it provides remarkable efficacy is bolstering the growth of the market.
Regional Insights:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America (the United States and Canada) was the largest market for gene therapy. Some of the factors driving the North America gene therapy market included the rising awareness about the benefits of gene therapy in treating various chronic diseases and the increasing expenditure in research and development (R&D) activities to develop effective gene therapies is propelling the market growth. In addition, the growing construction of various healthcare facilities to provide quality treatment to patients is propelling the growth of the market.
Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global gene therapy market. Some of the companies covered in the report include:
Abeona Therapeutics Inc.
Adaptimmune Therapeutics plc
Adverum Biotechnologies Inc.
Amgen Inc.
Astellas Pharma Inc.
Biogen Inc.
Bluebird Bio Inc.
Mustang Bio Inc. (Fortress Biotech Inc.)
Novartis AG
Orchard Therapeutics plc
UniQure N.V.
Voyager Therapeutics Inc.
Please note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Questions Answered in This Report
1. What was the size of the global gene therapy market in 2022?
2. What is the expected growth rate of the global gene therapy market during 2023-2028?
3. What are the key factors driving the global gene therapy market?
4. What has been the impact of COVID-19 on the global gene therapy market?
5. What is the breakup of the global gene therapy market based on the vector type?
6. What is the breakup of the global gene therapy market based on the application?
7. What are the key regions in the global gene therapy market?
8. Who are the key players/companies in the global gene therapy market?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Gene Therapy Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Gene Type
6.1 Antigen
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Cytokine
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Tumor Suppressor
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Suicide Gene
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Deficiency
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Growth Factors
6.6.1 Market Trends
6.6.2 Market Forecast
6.7 Receptors
6.7.1 Market Trends
6.7.2 Market Forecast
6.8 Others
6.8.1 Market Trends
6.8.2 Market Forecast
7 Market Breakup by Vector Type
7.1 Viral Vector
7.1.1 Market Trends
7.1.2 Key Segments
7.1.2.1 Adenoviruses
7.1.2.2 Lentiviruses
7.1.2.3 Retroviruses
7.1.2.4 Adeno-Associated Virus
7.1.2.5 Herpes Simplex Virus
7.1.2.6 Poxvirus
7.1.2.7 Vaccinia Virus
7.1.2.8 Others
7.1.3 Market Forecast
7.2 Non-Viral Techniques
7.2.1 Market Trends
7.2.2 Key Segments
7.2.2.1 Naked and Plasmid Vectors
7.2.2.2 Gene Gun
7.2.2.3 Electroporation
7.2.2.4 Lipofection
7.2.2.5 Others
7.2.3 Market Forecast
8 Market Breakup by Delivery Method
8.1 In-Vivo Gene Therapy
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Ex-Vivo Gene Therapy
8.2.1 Market Trends
8.2.2 Market Forecast
9 Market Breakup by Application
9.1 Oncological Disorders
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Rare Diseases
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Cardiovascular Diseases
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Neurological Disorders
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Infectious Disease
9.5.1 Market Trends
9.5.2 Market Forecast
9.6 Others
9.6.1 Market Trends
9.6.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Abeona Therapeutics Inc.
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.2 Adaptimmune Therapeutics plc
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.3 Adverum Biotechnologies Inc.
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.4 Amgen Inc.
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 Astellas Pharma Inc.
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6 Biogen Inc.
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 Bluebird Bio Inc.
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Mustang Bio Inc. (Fortress Biotech Inc.)
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.9 Novartis AG
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Orchard Therapeutics plc
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.11 UniQure N.V.
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.12 Voyager Therapeutics Inc.
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
15.3.12.3 Financials
Figure 1: Global: Gene Therapy Market: Major Drivers and Challenges
Figure 2: Global: Gene Therapy Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Gene Therapy Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Gene Therapy Market: Breakup by Gene Type (in %), 2022
Figure 5: Global: Gene Therapy Market: Breakup by Vector Type (in %), 2022
Figure 6: Global: Gene Therapy Market: Breakup by Delivery Method (in %), 2022
Figure 7: Global: Gene Therapy Market: Breakup by Application (in %), 2022
Figure 8: Global: Gene Therapy Market: Breakup by Region (in %), 2022
Figure 9: Global: Gene Therapy (Antigen) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Gene Therapy (Antigen) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Gene Therapy (Cytokine) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Gene Therapy (Cytokine) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Gene Therapy (Tumor Suppressor) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Gene Therapy (Tumor Suppressor) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Gene Therapy (Suicide Gene) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Gene Therapy (Suicide Gene) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Gene Therapy (Deficiency) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Gene Therapy (Deficiency) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Gene Therapy (Growth Factors) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Gene Therapy (Growth Factors) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Gene Therapy (Receptors) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Gene Therapy (Receptors) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Gene Therapy (Other Gene Types) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Gene Therapy (Other Gene Types) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Gene Therapy (Viral Vector) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Gene Therapy (Viral Vector) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Gene Therapy (Non-Viral Techniques) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Gene Therapy (Non-Viral Techniques) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Global: Gene Therapy (In-Vivo Gene Therapy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Global: Gene Therapy (In-Vivo Gene Therapy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Global: Gene Therapy (Ex-Vivo Gene Therapy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Global: Gene Therapy (Ex-Vivo Gene Therapy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: Global: Gene Therapy (Oncological Disorders) Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: Global: Gene Therapy (Oncological Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Global: Gene Therapy (Rare Diseases) Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Global: Gene Therapy (Rare Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: Global: Gene Therapy (Cardiovascular Diseases) Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: Global: Gene Therapy (Cardiovascular Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: Global: Gene Therapy (Neurological Disorders) Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: Global: Gene Therapy (Neurological Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: Global: Gene Therapy (Infectious Disease) Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: Global: Gene Therapy (Infectious Disease) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: Global: Gene Therapy (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: Global: Gene Therapy (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: North America: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: North America: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: United States: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: United States: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: Canada: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: Canada: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: Asia-Pacific: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: Asia-Pacific: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: China: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: China: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: Japan: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: Japan: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: India: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: India: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: South Korea: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: South Korea: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: Australia: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: Australia: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: Indonesia: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: Indonesia: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: Others: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: Others: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: Europe: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: Europe: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: Germany: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: Germany: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: France: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: France: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: United Kingdom: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: United Kingdom: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Italy: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 76: Italy: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Spain: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 78: Spain: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 79: Russia: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 80: Russia: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 81: Others: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 82: Others: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 83: Latin America: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 84: Latin America: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 85: Brazil: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 86: Brazil: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 87: Mexico: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 88: Mexico: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 89: Others: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 90: Others: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 91: Middle East and Africa: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
Figure 92: Middle East and Africa: Gene Therapy Market: Breakup by Country (in %), 2022
Figure 93: Middle East and Africa: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 94: Global: Gene Therapy Industry: SWOT Analysis
Figure 95: Global: Gene Therapy Industry: Value Chain Analysis
Figure 96: Global: Gene Therapy Industry: Porter's Five Forces Analysis
Table 1: Global: Gene Therapy Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Gene Therapy Market Forecast: Breakup by Gene Type (in Million US$), 2023-2028
Table 3: Global: Gene Therapy Market Forecast: Breakup by Vector Type (in Million US$), 2023-2028
Table 4: Global: Gene Therapy Market Forecast: Breakup by Delivery Method (in Million US$), 2023-2028
Table 5: Global: Gene Therapy Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 6: Global: Gene Therapy Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 7: Global: Gene Therapy Market: Competitive Structure
Table 8: Global: Gene Therapy Market: Key Players
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security